Brief: Abionyx Pharma FY Revenues EUR 4.6 Mln, Down Vs EUR 5.3 Mln Yr Ago

Abionyx Pharma SA

11/03/2024 06:33

March 11 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ANNOUNCES ITS 2023 FULL-YEAR FINANCIAL RESULTS
    * FY REVENUES EUR 4.6 MILLION, VERSUS EUR 5.3 MILLION YEAR
AGO
    * FINANCIAL VISIBILITY HAS NOW BEEN EXTENDED TO Q1 2025
    * CASH AND CASH EQUIVALENTS AMOUNTED TO €4.10 MILLION AT
DECEMBER
31, 2023, COMPARED TO €4.05 MILLION AT DECEMBER 31, 2022

Source text for Eikon:  urn:newsml:reuters.com:*:nBw9NTvqZa
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))